Vericel (VCEL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Vericel Corporation  (NASDAQ: VCEL)
 

Vericel Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vericel Corporation inventory turnover ratio, the Vericel Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 4.3 in the second quarter 2026, yet the ratio remained below the average, as VCEL's market remain challenging.Average inventory processing period, for the Vericel in Jun 30 2026 quarter, has decreased to 85 days, compare to 88 days, in the Mar 31 2026 quarter.

Within Healthcare sector 87 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 918 in the first quarter 2026, to 962.

VCEL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vericel Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VCEL Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 9.22 % 7.28 % 1.08 % 15.23 % 13.06 %
Y / Y Cost of Sales Growth 26.63 % 17.36 % 17.26 % 10.25 % 3.52 %
Inventory Turnover Ratio (TTM) 4.3 4.15 4.06 3.9 3.94
VCEL's Total Ranking # 962 # 918 # 663 # 848 # 672
Average inventory processing period 85 88 90 94 93
Seq. Inventory Growth 0.17 % 4.5 % -3.28 % 7.87 % -1.61 %
Seq. Cost of Sales Growth 9.9 % -3.19 % 10.45 % 7.76 % 1.85 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 7
Healthcare Sector # 88
Overall Market # 962

Inventory Turnover Ratio Statistics
High Average Low
15.61 6.84 3.46
(Mar 31 2016)   (Dec 31 2022)



VCEL Company Profile >> Back to VCEL Efficiency Comparisons >> Compare VCEL Inventory Turnover Ratio to its Competitors

Financial Statements
Vericel's Inventories $ 18 Millions Visit VCEL's Balance sheet
Vericel's Cost of Revenues TTM $ 78 Millions Visit VCEL's Income Statement
What are VCEL's Sales? Visit VCEL's Sales by Segment

Other Inventory Turnover Ratios
Vericel's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VCEL's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VCEL's Competitors
Inventory Turnover Ratio for VCEL's Suppliers
Inventory Turnover Ratio for VCEL's Customers

You may also want to know
VCEL's Sales Growth Rates VCEL's Pe Price to earnings ratio VCEL's Receivables Turnover Ratio VCEL's Stock Quote
VCEL's Net Income Growth Rates VCEL's Ps Price to Sales ratio VCEL's Sales per Employee VCEL's Asset Turnover Ratio
VCEL's Net Margin VCEL's Pb Price to Book ratio VCEL's Financial Strength Ratios VCEL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.